LION: Late In-the-bag intraOcular Lens dislocatioN Surgery

Sponsor
Oslo University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03276104
Collaborator
South-Eastern Norway Regional Health Authority (Other)
50
1
2
62.7
0.8

Study Details

Study Description

Brief Summary

Overall aim of the study is to compare the safety and efficacy of two different surgical methods to treat Late In-the-bag intraocular lens dislocation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: IOL repositioning
  • Procedure: IOL exchange
N/A

Detailed Description

Cataract is a condition of unclear lens that cause poor vision. The only treatment is surgery where the blurred biological lens is replaced with an artificial clear lens (IOL). Most people who operate achieve full vision. Nevertheless, serious complications may occasionally occur, and one of these is dislocation of the entire complex with IOL and lens capsule. This requires surgical treatment.

In this study the investigators want to compare two different surgical methods used in late dislocation of IOL inside the capsule after cataract surgery. Patients will be randomly affiliated to either the suturing of existing IOL / capsule complex, or lens exchange to an IOL fixed to the iris.

The focus of the trial will be especially on complications and other eye changes in the early stages of surgery. Today, little data is available on these topics, and the investigators believe that new knowledge can bring us closer to a response to preferred operating techniques and an optimal drug drop regime for the patient group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized clinical trialRandomized clinical trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Masking of research optometrists to group affiliation at the postoperative examinations will be endeavored. A physician will perform slit lamp examinations at the postoperative visits, hence he/she cannot be masked, nor can the surgeon. The investigator will be masked during the image analysis.
Primary Purpose:
Treatment
Official Title:
Late In-the-bag intraOcular Lens dislocatioN Surgery: A Randomized Clinical Trial (LION Trial)
Actual Study Start Date :
Sep 9, 2017
Anticipated Primary Completion Date :
Nov 1, 2020
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: IOL repositioning group

Procedure: IOL repositioning
Intraocular lens repositioning by scleral suturing

Active Comparator: IOL exchange group

Procedure: IOL exchange
Intraocular lens exchange with retropupillary iris-claw lens

Outcome Measures

Primary Outcome Measures

  1. Inflammation in the anterior chamber after surgery [The first weeks after surgery]

    Measured with a Laser Flare Meter

  2. Changes in macular thickness and occurrence of Cystoid macular edema [The first months after surgery, and long term changes months up to two years after surgery]

    Evaluated with Optical Coherence Tomography

  3. Intraocular pressure changes [Early changes in the first weeks after surgery, and long term changes months up to two years after surgery]

    Measured with Goldmann Applanation Tonometry and iCare, both measured in mmhg

Secondary Outcome Measures

  1. Best Corrected Visual acuity (BCVA) [Short term (the first weeks and up to 6 months) and long term (up to two years)]

    Measured in LogMar

  2. Best Corrected Visual acuity (BCVA) [Short term (the first weeks and up to 6 months) and long term (up to two years)]

    Measured in Snellen

  3. Glare [Medium term (6 months)]

    Measured by straylight meter

  4. Glare [Medium term (6 months)]

    Measured by subjective presence of glare

  5. Endothelial cells [Short term (2 weeks) and long term (6months and 2 years)]

    Measured by Non-contact corneal confocal microscopy

  6. Intra- and postoperative complications [Short term and long term (first post operative day, the first weeks and months, and up to two years)]

    All relevant complications

  7. IOL tilt [6 months and 2 years]

    Measured with anterior segment Ultra Sound

  8. IOL tilt [6 months and 2 years]

    Measured with Anterior segment optical coherence tomography

  9. Refractive outcomes - subjective refraction measured with a phoropter [Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years]

    To compare the refractive outcomes (short and long-term)

  10. Refractive outcomes - subjective refraction measured with a phoropter [Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years]

    To determine whether suture placement for IOL repositioning affects the refractive outcome

  11. Astigmatism [Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years]

    To compare astigmatism measured by keratometry

  12. Astigmatism [Short term - meaning 2 weeks to 6 months. Long term - meaning up to two years]

    To compare astigmatism measured by subjective refraction measured with phoropter

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • IOL inside the capsule ("in-the-bag")

  • Late dislocation (more than 6 months after cataract surgery)

  • IOL visible in the pupillary area in the supine position and hence possible to perform surgery with an anterior approach

  • Eligibility for both operation methods

  • Ability to cooperate fairly well during the examinations

  • Willing to participate in the study, e.g. willingness to participate at all control visits

Exclusion Criteria:
  • IOL designs that cannot be repositioned with a suture loop, such as plate-haptic IOLs without holes in the peripheral part

  • Eyes with especially thin sclera

  • Active uveitis or pronounced iris pathology

  • Eyes with previously performed Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)

  • Totally dislocated IOL into the posterior segment of the eye requiring pars plana vitrectomy

  • Eyes that prior to cataract extraction had a subluxated lens in need of surgery with a Cionni capsular tension ring (e.g. patients with Marfan syndrome and ectopia lentis)

  • Cases requiring a change in refraction. Risk of severe anisometropia

  • Patients unable to lie in supine position for surgery in local anesthesia, e.g. severe chronic obstructive pulmonary disease and severe heart failure

  • Patients using anticoagulants that cannot be discontinued

For patients with dislocated IOLs in both eyes during the study period, only the first operated eye will be included. Patients without prospects of improvement in vision will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oslo University Hospital Oslo Norway

Sponsors and Collaborators

  • Oslo University Hospital
  • South-Eastern Norway Regional Health Authority

Investigators

  • Study Chair: Liv Drolsum, Prof. M.D. PhD, Oslo University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marius Dalby, Principal Investigator, M.D., PhD Candidate, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT03276104
Other Study ID Numbers:
  • 2017/5506
First Posted:
Sep 8, 2017
Last Update Posted:
Apr 17, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marius Dalby, Principal Investigator, M.D., PhD Candidate, Oslo University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 17, 2019